In both sporadic and familial PCT, studies demonstrate reduced UROD catalytic activity despite normal UROD protein levels, suggesting the generation of a UROD inhibitor that is highly dependent on the presence of excess hepatic iron [1,13]. The gene discussed is UROD; the disease is porphyria cutanea tarda.